Home » Topics » BioWorld Science

BioWorld Science
RSS

Large-scale proteomic analysis unveils a shift in glutaminate fate involved in cancer progression

April 7, 2020

Head and neck cancer cachexia mouse model developed

April 7, 2020

The dose makes the poison -- timing, too

April 7, 2020

Smart bacterium senses environment

April 7, 2020

FDA approves Reblozyl to treat anemia in MDS

April 6, 2020

Union Therapeutics announces program with optimized salt form of niclosamide to treat COVID-19

April 6, 2020

European Commission approves Rybelsus for type 2 diabetes

April 6, 2020

SHR-1701 begins new phase I trials for advanced solid tumors and nasopharyngeal carcinoma

April 6, 2020

New HER2 inhibitors identified by Suzhou Zanrong Pharma

April 6, 2020

ViiV Healthcare presents compounds for HIV infection

April 6, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...